Table 2. Recommended intramuscular medications for rapid tranquilization in psychomotor agitation* .
Medication | Dosage (mg) | Initial effects | Half-life | Can repeat | Maximum dosage per 24 h (mg) | Side effects | Level of evidence | Grade of recommendation |
---|---|---|---|---|---|---|---|---|
Haloperidol | 2.5-10 | 30 min | 15-37 h | 30 min | 30 | Seizure, EPS, somnolence, headache, dizziness. | 1A | A |
Haloperidol + midazolam | 2.5 + 7.5-15 | 20 min | 15 h | 30 min | 30 for haloperidol | Excessive sedation, EPS. | 1A | A |
Haloperidol + promethazine | 2.5-10 + 25-50 | 30 min | 15-37 h | 30 min | 30/100 | Excessive sedation, EPS, seizure | 1A | A |
Lorazepam† | 2-4 | 20-30 min | 13-18 h | 1 h | 4 | Respiratory difficulty, nausea, dizziness with lorazepam | 1A | A |
Midazolam | Up to 15 | 15-20 min | 90-150 min | 30 min | - | Over sedation, respiratory depression | 1A | A |
Olanzapine | 2.5-10 | 15-45 min | Excessive sedation, EPS, orthostatic hypotension, somnolence, blood urine | 1A | A | |||
Ziprasidone | 10-20 | 1 h | 2-5 h | 10 (2 h)/20 (4 h) | 40 | Excessive sedation, EPS | 1A | A |
Aripiprazole† | 9.75 | 1-3 h | 75-94 h | 2 h | 30 | Headache, dizziness, nausea, insomnia, EPSs, tachycardia | 1B | A |
Droperidol | 2.5-10 | 3-10 min | 3 h | 30 min | 20 | Abnormal QT, hypotension, dizziness, EPS | 2B | B |
Droperidol+ midazolam | 10 + 5 | 15 min | 2 h | 30 min | 20/15 | Abnormal QT, oversedation, respiratory depression | 2B | B |
Flunitrazepam† | 1-2 | 2 h | 18-26 h | 24 h | 2 | Respiratory arrest, oversedation, hypersalivation, drowsiness, dizziness, amnesia | 2B | B |
Haloperidol + lorazepam† | 5 + 2 | 30 min | 18 h | 1 h | 15/4 | Excessive sedation, EPS | 2B | B |
Levomepromazine† | 12.5-25 | 20-40 min | 30 h | 6 h | 100 | Abnormal QT, hypotension, dizziness, EPS | 2C | B |
Clonazepam† | 1-2 | 0.5-1 h | 20-80 h | 3 h | 8 | Respiratory arrest, oversedation, hypersalivation, drowsiness, dizziness, amnesia | 4 | C |
Only recommended formulations are included. Vital signs and electrocardiogram (ECG) monitoring are recommended for patients with high cardiac risk or unknown history.
Not available in Brazil.
EPS = extrapyramidal side effects.